This U.S. healthcare stock is Mizuho’s top pick after strong Q3 results
UnitedHealth Group (UNH) reported stronger-than-expected Q3 results, beating EPS estimates by 13% and improving its medical loss ratio. Mizuho Securities attributes this to strong performances at UnitedHealthcare and OptumHealth, maintaining an 'outperform' rating and naming UNH its top healthcare pick. Investors focus on sustained profitability and 2027 earnings growth outlook.
How this was made
The 30-second read
Why it matters
The earnings beat reinforces UNH's growth narrative and may attract further buying from healthcare‑focused funds.
Market read
Strong Q3 results could drive short‑term price appreciation for UNH and positively influence the health‑care sector.
What to watch
Potential headwinds from Medicare Advantage enrollment trends and regulatory cost pressures.
Background
Mizuho Securities highlighted UnitedHealth as its top pick in the U.S. healthcare sector after the earnings beat.
Ticker impact
UnitedHealth reported Q3 earnings beating EPS estimates by 13% and improving medical loss ratio, a fresh earnings disclosure.
likely upward pressure as investors price in stronger profitability.
Beat on earnings and margin improvement are new, material data for a large‑cap health insurer.
Market effects
May lift broader healthcare sector as peers are compared to UNH's margin recovery.
U.S. market could see modest gains in health‑care indices.
Limited to U.S. investors; global insurers may watch for trend signals.
Counterpoint
Some analysts may argue the improvement is driven by prior‑period adjustments and could be unsustainable.
Key entities
- analystMizuho Securities
Broker that upgraded UNH to outperform.

